Skip to content

COPPIN BIOLOGICAL SOLUTIONS

Active Private limited companyfounded 2023active for 3 yearsBeekomstraat 13, 3740 Bilzen-HoeseltKBO/BCE: BE 0801.563.854

Lifetime

2 annual accounts with figures on one time axis
peak of €28,688 in 2024
€19,738▼ 31.2%
peak of €16,531 in 2024
€12,706▼ 23.1%
peak of €33,237 in 2025
€33,237▲ 61.9%
€46,808▼ 19.7%
Board1 name since 2023
1 director
Documentsfilings and deeds
09-07-202622 days before the deadline
2025micro format
Gross margin from €28,688 to €19,738Equity from €20,531 to €33,237Debts from €58,269 to €46,808Investments €5,299

Key points

from the 2025 annual accounts

Turnover

≈ €81,000 estimated

The micro format states no turnover.

Investments

€5,299 3.0 times depreciation
20242025

Green is investment, beige is depreciation.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as COPPIN BIOLOGICAL SOLUTIONS has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for COPPIN BIOLOGICAL SOLUTIONS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 10-05-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0801563854
Incorporation Founding capital of €4,000, 100 shares · Founded by · appointed as director · published on 10-05-2023 · Gazette deed
First establishment Groen Creaties Coppin/Coppin Biological Solutions, Beekomstraat 13, Bilzen-Hoeselt
All 5 events

Comparable companies

same main activity, similar in size and age
Company
COPPIN BIOLOGICAL SOLUTIONS Bilzen-Hoeselt €80,045 €19,738 41.5% -
Le jardin des paysagistes Court-Saint-Etienne €127,912 €69,934 51.9% -
Les Pépinières d'Enghien Enghien €167,122 €72,448 49.7% -
a.sierplant.be Wingene €302,320 €25,693 8.4% -
VENERECE Wavre €132,678 €10,009 9.1% -
Vandecraen buitenaannemingen Bruges €368,439 €62,300 26.5% -
THERESE DE BRUYNE Aalst €86,861 €41,759 49.1% -

These companies have the same main activity as COPPIN BIOLOGICAL SOLUTIONS: crop and animal production, hunting and related service activities (NACE 01309). They are comparable in size and age: total assets between €86,900 and €368,000, founded between 2001 and 2023.

Official details

Source: KBO
Status
Active since 08-05-2023Normal situation
Activity
Crop and animal production, hunting and related service activitiesNACE 01309and 5 others
Establishment unit
2.345.040.7223740 Bilzen-Hoeselt, since 08-05-2023
Financial year end
31 December
Peppol
Reachable since 22-12-2024
Company details

Annual accounts 2025

€80,045▲ 1.6%
Filing
Filed on 09-07-2026, 22 days before the end of the filing period
Financials

Insights on COPPIN BIOLOGICAL SOLUTIONS

COPPIN BIOLOGICAL SOLUTIONS has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €33,237 and a net result of €12,706.

Its solvency ranks better than 58% of 4,038 sector peers (NACE 01) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about COPPIN BIOLOGICAL SOLUTIONS

What is the company number of COPPIN BIOLOGICAL SOLUTIONS?
The company number of COPPIN BIOLOGICAL SOLUTIONS is 0801.563.854. The VAT number is the same number with BE in front: BE 0801.563.854.
Where is COPPIN BIOLOGICAL SOLUTIONS based?
The registered office is at Beekomstraat 13, 3740 Bilzen-Hoeselt.Company details
What does COPPIN BIOLOGICAL SOLUTIONS do?
According to the KBO register, the main activity is crop and animal production, hunting and related service activities (NACE 01309).
What is the legal form of COPPIN BIOLOGICAL SOLUTIONS?
COPPIN BIOLOGICAL SOLUTIONS is a private limited company (BV).
When was COPPIN BIOLOGICAL SOLUTIONS founded?
COPPIN BIOLOGICAL SOLUTIONS was founded on 08-05-2023.
Is COPPIN BIOLOGICAL SOLUTIONS still active?
Yes, COPPIN BIOLOGICAL SOLUTIONS is an active enterprise in the KBO register.
What is the turnover of COPPIN BIOLOGICAL SOLUTIONS?
The turnover in financial year 2025 is ≈ €81,000. This figure is estimated from the gross margin of €19,738 and 40 comparable companies (NACE 01). It probably lies between €35,000 and €210,000. It is a rough estimate.Financials
Is COPPIN BIOLOGICAL SOLUTIONS profitable?
In financial year 2025, COPPIN BIOLOGICAL SOLUTIONS made a profit of €12,706.
Where can I find the annual accounts of COPPIN BIOLOGICAL SOLUTIONS?
COPPIN BIOLOGICAL SOLUTIONS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of COPPIN BIOLOGICAL SOLUTIONS due?
COPPIN BIOLOGICAL SOLUTIONS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.